rs77825059

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000503.6(EYA1):​c.782C>T​(p.Pro261Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000644 in 1,614,064 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. P261P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00092 ( 2 hom., cov: 33)
Exomes 𝑓: 0.00062 ( 10 hom. )

Consequence

EYA1
NM_000503.6 missense

Scores

1
8
9

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 9.52

Publications

7 publications found
Variant links:
Genes affected
EYA1 (HGNC:3519): (EYA transcriptional coactivator and phosphatase 1) This gene encodes a member of the eyes absent (EYA) family of proteins. The encoded protein may play a role in the developing kidney, branchial arches, eye, and ear. Mutations of this gene have been associated with branchiootorenal dysplasia syndrome, branchiootic syndrome, and sporadic cases of congenital cataracts and ocular anterior segment anomalies. A similar protein in mice can act as a transcriptional activator. Alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Dec 2013]
EYA1 Gene-Disease associations (from GenCC):
  • branchio-oto-renal syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • branchiootorenal syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • branchiootic syndrome 1
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • branchiootic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009139895).
BP6
Variant 8-71299091-G-A is Benign according to our data. Variant chr8-71299091-G-A is described in ClinVar as Benign. ClinVar VariationId is 363655.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000919 (140/152260) while in subpopulation EAS AF = 0.0231 (119/5160). AF 95% confidence interval is 0.0197. There are 2 homozygotes in GnomAd4. There are 75 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 140 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EYA1NM_000503.6 linkc.782C>T p.Pro261Leu missense_variant Exon 9 of 18 ENST00000340726.8 NP_000494.2 Q99502-1A0A024R813B3KXR1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EYA1ENST00000340726.8 linkc.782C>T p.Pro261Leu missense_variant Exon 9 of 18 1 NM_000503.6 ENSP00000342626.3 Q99502-1

Frequencies

GnomAD3 genomes
AF:
0.000920
AC:
140
AN:
152142
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.0230
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00212
AC:
534
AN:
251472
AF XY:
0.00192
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00357
Gnomad EAS exome
AF:
0.0258
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000439
Gnomad OTH exome
AF:
0.000814
GnomAD4 exome
AF:
0.000616
AC:
900
AN:
1461804
Hom.:
10
Cov.:
32
AF XY:
0.000586
AC XY:
426
AN XY:
727202
show subpopulations
African (AFR)
AF:
0.0000896
AC:
3
AN:
33476
American (AMR)
AF:
0.0000224
AC:
1
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00295
AC:
77
AN:
26132
East Asian (EAS)
AF:
0.0173
AC:
685
AN:
39692
South Asian (SAS)
AF:
0.000278
AC:
24
AN:
86250
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000468
AC:
52
AN:
1111956
Other (OTH)
AF:
0.000927
AC:
56
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
51
103
154
206
257
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000919
AC:
140
AN:
152260
Hom.:
2
Cov.:
33
AF XY:
0.00101
AC XY:
75
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41558
American (AMR)
AF:
0.0000654
AC:
1
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00202
AC:
7
AN:
3470
East Asian (EAS)
AF:
0.0231
AC:
119
AN:
5160
South Asian (SAS)
AF:
0.000622
AC:
3
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000735
AC:
5
AN:
68018
Other (OTH)
AF:
0.00189
AC:
4
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
7
15
22
30
37
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000775
Hom.:
5
Bravo
AF:
0.00105
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.00213
AC:
258
Asia WGS
AF:
0.00722
AC:
25
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Nov 23, 2022
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 07, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Pro261Leu in Exon 08 of EYA1: This variant is not expected to have clinical sign ificance because it has been identified in 5.8% (7/120) of chromosomes from a po pulation in the dbSNP database (http://www.ncbi.nlm.nih.gov/projects/SNP; rs7782 5059). -

Branchiootic syndrome 1 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Melnick-Fraser syndrome Benign:1
Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Dec 27, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 24429398) -

Otofaciocervical syndrome 1 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.027
T
BayesDel_noAF
Pathogenic
0.21
CADD
Pathogenic
32
DANN
Uncertain
0.99
DEOGEN2
Benign
0.39
T;T;T;.;.;.;T;T;.;.;.;.;.
Eigen
Uncertain
0.36
Eigen_PC
Uncertain
0.50
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Uncertain
0.96
.;.;.;D;D;D;.;D;D;D;D;D;D
MetaRNN
Benign
0.0091
T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
-0.17
T
MutationAssessor
Benign
0.83
L;L;L;.;.;.;L;L;.;.;.;.;.
PhyloP100
9.5
PrimateAI
Uncertain
0.78
T
PROVEAN
Benign
-1.6
N;.;N;N;N;N;.;.;.;.;.;N;N
REVEL
Uncertain
0.49
Sift
Benign
0.20
T;.;T;T;T;T;.;.;.;.;.;T;T
Sift4G
Benign
0.35
T;.;T;T;T;T;.;.;.;.;.;T;T
Polyphen
1.0
D;D;D;.;B;D;D;D;.;.;.;.;.
Vest4
0.74
MVP
0.80
MPC
0.84
ClinPred
0.050
T
GERP RS
5.2
Varity_R
0.21
gMVP
0.65
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77825059; hg19: chr8-72211326; COSMIC: COSV58171058; API